Strategic Finance
Leadership,
On Demand
25+ years transforming financial operations for biopharmaceutical and growth-stage companies. Board-ready insights and sustainable growth.
~600%
Market Cap Growth
$17B+
Planning Scope
25+
Years Experience
Yasser Hazzaa
Fractional CFO & Strategic Finance Advisor
25+ years leading finance transformation across global biopharma — from pre-revenue startups to $17B+ enterprises. I bring board-ready financial leadership without the full-time overhead.
Performance Dashboard
Executive Impact
25+
Years Finance Leadership
Bristol-Myers Squibb & MannKind Corporation
3
Continents Led
North America, Europe, Africa/Middle East
150+
Global FP&A Community
Built & mentored at BMS
2
Board Positions
TesoRx Pharma and Lipac Oncology
Finance Leadership
Without Boundaries
I am a global finance executive with over 25 years of experience driving shareholder value, operational excellence, and strategic transformation across biopharmaceutical companies.
My career began in engineering, where I developed a rigorous analytical and systems-thinking mindset that now underpins my strategic finance leadership.
From leading FP&A for a $17B business to supporting ~600% market cap growth — results in dynamic, high-stakes environments.
Previously served as a Board Member at TesoRx Pharma and Lipac Oncology through February 2026, providing oversight on audit and finance matters while continuing to advise growth-stage companies on their financial journey.
Education
MBA, Maastricht School of Management
Credentials
CPA (California)
Languages
English, Arabic (Fluent)
Location
Oak Park, CA
Career Timeline
2025–Feb 2026
Board Member
TesoRx Pharma & Lipac Oncology
Audit and finance oversight for clinical-stage biopharma companies (ended Feb 2026).
2017–2025
Vice President of Finance & Treasurer
MannKind Corporation
Financial discipline supporting ~600% market cap growth over seven years.
2015–2016
Lead, FP&A Center of Excellence
Bristol Myers Squibb
Built global FP&A community of 150+ professionals.
2011–2015
Director, Corporate FP&A
Bristol Myers Squibb
Led Long-Term Financial Plan for $17B business.
2009–2010
Associate Director Finance – Europe
Bristol Myers Squibb, Paris
EMEA Medicines finance leadership across 30+ markets.
2005–2009
Finance Director Roles
Bristol Myers Squibb, Paris & Cairo
Progressive leadership across EMEA region.
1994–2004
Financial Analyst to Manager
Bristol Myers Squibb
Foundation in financial planning and analysis.
Finance Leadership,
Scaled to Your Needs
From strategic planning to board presentations, I deliver the financial infrastructure and insights that drive confident decision-making.
CFO Consulting
Executive-level financial leadership without the full-time overhead. Strategic guidance for growth-stage companies navigating complex financial decisions.
- —Board & investor presentations
- —Strategic financial planning
- —Executive coaching
FP&A & Forecasting
Build robust forecasting models and reporting frameworks that give leadership clarity and confidence in every decision.
- —Budgeting & long-range planning
- —KPI dashboards (Power BI)
- —Variance analysis
Capital Strategy
Optimize your capital structure and allocation to fuel growth while maintaining financial stability.
- —Liquidity management
- —Treasury strategy
- —Working capital optimization
M&A Due Diligence
Comprehensive financial diligence that protects value and surfaces critical risks before deals close.
- —Target evaluation
- —Integration planning
- —Risk assessment
Board-Ready Reporting
Clear, compelling financial narratives that help boards make informed strategic decisions.
- —SEC filing support
- —Audit committee materials
- —Investor relations
Performance Transformation
Identify and execute on operational improvements that drive sustainable profitability.
- —Cost optimization
- —Process automation
- —Team development
Outcomes That Speak
A career defined by delivering measurable financial transformation for global biopharmaceutical organizations.
~600%
Market Cap Growth
MannKind Corporation
Vice President of Finance & Treasurer, 2017–2025
Partnered with Executive Leadership Team to achieve 600% growth in enterprise value through rigorous FP&A and capital strategy during a transformative seven-year growth cycle.
20%+
Reporting Cycle Reduction
MannKind Corporation
Vice President of Finance & Treasurer
Optimized reporting workflows with Power BI automation; reduced reporting cycle time by more than 20 percent and strengthened decision velocity.
150+
Global FP&A Community
Bristol Myers Squibb
FP&A COE Lead, 2015–2016
Built a global FP&A community driving process excellence and capability development across the organization.
$17B
Planning Scope
Bristol Myers Squibb
Director Corporate FP&A, 2011–2015
Led Long-Term Financial Plan and served as Global Finance Lead for Virology, Neuroscience, and Immuno-science franchises.
Ready to see similar results for your organization?
Schedule ConsultationReady to Accelerate
Your Financial Strategy?
Whether you need interim CFO leadership, board advisory, or strategic financial planning — let's discuss how I can support your organization's goals.
Schedule ConsultationSchedule Consultation
Fill out the form below to get started